We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
DxGen Corp.

Download Mobile App





FDA Develops Fecal Test for COVID-19

By LabMedica International staff writers
Posted on 14 Dec 2020
Print article
Illustration
Illustration
The US Food and Drug Administration (FDA Silver Spring, MD, USA) has developed a test for COVID-19 in fecal matter that aims to prevent the disease from being inadvertently transmitted during fecal transplantation.

Fecal microbiota transplantation (FMT) is a modern method in which microbes usually found in the human gut and are part of a healthy body are transplanted into patients who are suffering from conditions such as clostridium difficile infection, a pathogen that is generally transmitted in healthcare settings. The unsupervised use of FMT by people lacking medical training can lead to the transmission of pathogens. Additionally, there are concerns about pathogens transmitted in medical settings and the FDA has received reports of the novel coronavirus found in the stool of patients.

There is no validated stool test as of now, although Paul Carlson, principal investigator in the Laboratory of Mucosal Pathogens and Cellular Immunology at FDA’s Office of Vaccines Research and Review said that his office has developed a “working assay for detection” of the coronavirus responsible for COVID-19 in stool in results confirmed independently by a laboratory at Stanford University. Carlson’s office was concerned that asymptomatic individuals infected with COVID-19 would unknowingly becoming FMT donors.

Speaking during a webinar that was organized by the agency’s Office of Scientific Professional Development, Carlson said, “we advised no use of fecal donations from after Dec. 1, 2019, until effective screening methods are implemented. There were no methods for testing for COVID in stool. We know now that the viral RNA is found in stool and infectious virus as well. Infection in the GI tract is likely.”

A scientific paper on the test is now in pre-publication and the method could have other research uses, according to Carlson.

Related Links:
US Food and Drug Administration (FDA)

Gold Supplier
Streptococcus Test
STREPA’LERT
Nucleic Acid Purification Kit
Maxwell RSC Viral Total Nucleic Acid Purification Kit
Laboratory Automation Solution
SATLAS-TCA
COVID-19 Anitibody Test
TGS COVID-19 IgG

Print article

Channels

Molecular Diagnostics

view channel
Image: Micrograph of a colorectal adenocarcinoma (Photo courtesy of Wikimedia Commons)

Plasma or Urine Liquid Biopsy Tests May Guide Colorectal Cancer Treatment

A recent paper suggested that liquid biopsy examination of blood or urine could aid in evaluating the effectiveness of therapy for colorectal cancers that had begun to metastasize beyond the site of the... Read more

Industry

view channel
Image: Sysmex CN-Series automated blood coagulation analyzer (Photo courtesy of Sysmex Corporation)

Siemens and Sysmex Extend Agreement to Provide One of the Largest Portfolios of Hemostasis Testing Systems and Reagents

Siemens Healthineers (Erlangen, Germany) and Sysmex Corporation (Kobe, Japan) have renewed their long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.